Skip to content
The heads of the three largest pharmacy benefit managers (PBMs) were grilled on July 23 by the House Oversight and Accountability Committee, whose new […]
House Oversight Committee grills PBM executives over ‘despicable’ practices Read More »
Farmers, biotech firms, the federal government, and other stakeholders are cooperating closely to tackle the emerging challenge of protecting cattle against avian flu, said
Public-private partnerships drive response to avian flu in cattle, panel says Read More »
The House Ways and Means Committee learned how lawmakers can enable progress in biotech from a Biotechnology Innovation Organization (BIO) Board member and the
BIO Board member and head of BioUtah testify at House field hearing Read More »
With rapid innovations in agriculture, energy, and environmental biotech, the industry must try to educate regulators and the public about the latest scientific advances
BIO 2024: Education can improve regulation, biotech innovators say Read More »
Getting government support for a biotech startup no longer need be a slow and painful process, according to staff and fundees of the Advanced
ARPA-H offers fast, flexible support to biotech startups, panelists tell BIO 2024 Read More »
Biopharma supply chains, streamlining regulation, and other critical issues came up when the leader of the U.S. agency regulating drugs spoke with the leader
FDA’s Dr. Califf talks supply chains, clinical trial diversity, and America’s health Read More »
The pollster pulled no punches: The biopharma industry has a poor public image, and politicians in both parties are ready to back drug price
Biotech needs to polish its message as elections approach, experts say Read More »
To ensure national security in the face of potential biological threats, the U.S. government relies on a partnership with biotech firms, federal officials explained
BIO 2024: U.S. officials describe national security partnership with biotech Read More »
A lawsuit from a lawyer who is claiming whistleblower status while actually revealing well-known public information threatens to rattle the patent system, endangering drug
BIO asks Supreme Court to review a case threatening patents Read More »
Several federal agencies on May 8 announced a plan to coordinate and streamline regulation of plants, animals, and microorganisms modified through biotechnology. The plan
EPA, FDA, and USDA release plan to improve biotech regulation Read More »
